e-learning
resources
Paris 2018
Wednesday, 19.09.2018
Progress in basic and translational research on idiopathic interstitial pneumonias
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Synergistic Drug Combination of Nintedanib and Vardenafil Inhibits Fibrosis in AKR-2B Fibroblasts
M. Bourne (Rochester, United States of America), T. Kottom (Rochester, United States of America), A. Limper (Rochester, United States of America)
Source:
International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Session:
Progress in basic and translational research on idiopathic interstitial pneumonias
Session type:
Oral Presentation
Number:
5360
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Bourne (Rochester, United States of America), T. Kottom (Rochester, United States of America), A. Limper (Rochester, United States of America). Synergistic Drug Combination of Nintedanib and Vardenafil Inhibits Fibrosis in AKR-2B Fibroblasts. 5360
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
PP212 – The Anti-Fibrotic Drug Nintedanib Promotes Repair Macrophages
Source: ERS Lung Science Conference 2021
Year: 2021
Erythromycin Reverses Nets-induced Corticosteroid Insensitivity By Inhibition Of The Pi3kd/akt Pathway
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
Understanding of Pharmacokinetics and Exposure Drives use of Nintedanib as a Positive Control Reference Item in a Rat Model of Bleomycin-Induced Fibrosis
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
LSC - 2021 - The Anti-Fibrotic Drug Nintedanib Promotes Repair Macrophages
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021
The Effect of Cordycepin and Simvastatin on Cigarettes Smoke Extract Induced Cytokine and Chemokine Production in Human Bronchial Epithelial Cells
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018
Local Administration of Targeted Liposomes Loaded with Everolimus for Interstitial Lung Disease in Systemic Sclerosis
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021
Inhibition of LncRNA MALAT1 Protects H9c2 Cells against Intermittent Hypoxia-Induced Injury by Targeting MiRNA-193a-3p
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020
TLR7 Expression Reveals Novel Bronchodilating Mechanism of Imidazoquinoline Agonists
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
A new Humanized Mouse Model for Idiopathic Pulmonary Fibrosis and Effects of Nintedanib Treatment
Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Year: 2018
Cigarette Smoke Extract Promotes Human Lung Myofibroblast Differentiation by the Induction of Endoplasmic Reticulum Stress
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019
Mast Cell Tryptase Enhances Wound-Healing via Protease-Activated Receptor-2 Dependent Migration in Human Bronchial Epithelial Cells
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021
RAGE Partially Mediates Cigarettes Smoke Extract induced Cytokine and Chemokine Production in Human Bronchial Epithelial Cells
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018
Evaluation of Idiopathic Pulmonary Fibrosis therapies, Pirfenidone and Nintedanib, in a Human Experimental Model of Fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019
Effects of Sustained and Intermittent Hypoxia on Human Lung Cancer Cells
Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing
Year: 2019
A First-in-Class PRS Inhibitor, DWN12088, as a Novel Therapeutic Agent for Systemic Sclerosis and Associated Interstitial Lung Disease
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021
Aerosolized TLR7 Imidazoquinoline Agonist Bronchodilates In Vivo
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Year: 2018
Late Breaking Abstract - Endothelial Cell-Specific Anticoagulation Reduces Inflammation in a Mouse Model of ALI
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
Acetylsalicylic Acid Prevents Intermittent Hypoxia-Induced Vascular Remodeling in a Murine Model of Sleep Apnea
Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia
Year: 2018
Curcumin as an Add-on Therapy of Moderate Partially Controlled Asthma
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017
Exosomes from Intermittent Hypoxia Treated Lung Adenocarcinoma Cell Line Up-regulate Programmed Death Ligand 1 Expression through HIF-1a Pathway in Macrophages
Source: Virtual Congress 2020 – Biological aspects of lung cancer
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept